Aquatic Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Aquatic Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	+3,240	New	+$1.66M	0.06%	405
2025 Q1	–	Sell	-15,032	Closed	-$4.64M	–	1484
2024 Q4	$4.64M	Buy	+15,032	New	+$4.23M	0.13%	213
2023 Q3	–	Sell	-3,600	Closed	-$832K	–	1487
2023 Q2	$832K	Buy	+3,600	New	+$975K	0.05%	344
2022 Q4	–	Sell	-2,300	Closed	-$149K	–	1632
2022 Q3	$149K	Buy	+2,300	New	+$160K	0.01%	676
2022 Q1	–	Sell	-1,100	Closed	-$93K	–	1332
2021 Q4	$93K	Buy	+1,100	New	+$90.4K	0.18%	144

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Aquatic Capital Management's MDGL Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 3,240 shares worth $1.74M. The stake represents 0.06% of the portfolio and ranks #405 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in MDGL as recently as Q4 2024.

Aquatic Capital Management first reported a position in MDGL in Q4 2021 and has held it in 5 quarters since. The position peaked at $4.64M in Q4 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Aquatic Capital Management held 3,240 shares of Madrigal Pharmaceuticals worth $1.74M as of Q2 2026.
Madrigal Pharmaceuticals was a new Aquatic Capital Management position in Q2 2026.
Madrigal Pharmaceuticals made up 0.06% of Aquatic Capital Management's portfolio in Q2 2026, its #405 holding.
Aquatic Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
Aquatic Capital Management's Madrigal Pharmaceuticals position peaked at $4.64M in Q4 2024.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.